blue cross blue shield cover glp-1 Digital health company Ro launches insurance-coverage checker to help patients navigate costs – NBC 5 Dallas-Fort Worth Blue Cross Blue Shield of

Compounding the difficulty with pharmacotherapy for obesity in patients with breast cancer, recent findings demonstrated that breast cancer survivors on aromatase inhibitors and antiobesity medications had poorer weight loss outcomes than patients on antiobesity medications without breast cancer and not on aromatase inhibitors [45]

But we need to investigate further to determine whether factors such as the dose and duration of treatment may or may not lead to any differences in outcomes. Reference: Bariatric surgery is more cost effective than newer weight loss drugs alone

Preclinical studies suggest that GLP-1 receptor activation can reduce inflammatory cytokine production and modulate immune responses in ways that could be protective against infection

Dose escalation study in diet-induced obese male rats Male Wistar rats (Ex-4 group, n = 4

Leptin is proinflammatory and profibrotic, as it induces hepatic Kupffer cells to release inflammatory cytokines including tumor necrosis factor (TNF)-alpha as well as profibrogenic cytokines such as transforming growth factor (TGF)-beta, which induce a profibrogenic cascade in hepatic stellate cells [33]